-
-
[1]金诗湘.肝动脉栓塞化疗联合微波凝固治疗原发性肝癌疗效分析[J].中国基层医药, 2005, 12 (5) ∶603-604. [2]叶任高, 陆在英.内科学[M].北京:人民卫生出版社, 2004∶452. [3]罗健, 孙燕, 吴冠青, 等.癌症患者生活质量调查表的编制及测试[J].实用肿瘤杂志, 1996, 11 (6) ∶252-255. [4]Beasley R P.Hepatitis B virus:the major etiology of hepatocellull-ar carcinoma[J].Cancer, 1988, 61 (10) ∶1942-1948. [5]Ranki M, Schatzl HM, Zzchoval R, et al.Quanlification of hepati-tis B virus DNAovera wide range fromserumfor studying viral repli-cative in response to treatment and in recurrent infection[J].Hep-atology, 1995, 21 (6) ∶1492-1501. [6]ShawT, Locamini S.Entecavir for the treatment of chronic hepati-tis B[J].Expert Rev Anti Infect Ther, 2004, 2∶853-871. [7]赵志新.乙型病毒性肝炎相关晚期肝病的抗病毒治疗进展[J].新医学.2006, 31 (11) ∶757-758. [8]杨道坤, 王剑英, 梁海军, 等.博路定联合肝动脉化疗对HBsAg (+) 肝癌病人生存期的影响[J].医学信息手册分册, 2006, 19 (4) ∶78-79.
本文二维码
计量
- 文章访问数: 3460
- HTML全文浏览量: 4
- PDF下载量: 759
- 被引次数: 0